Nordic study on human milk fortification in extremely preterm infants: a randomised controlled trial-the N-forte trial

Georg Bach Jensen, Fredrik Ahlsson, Magnus Domellöf, Anders Elfvin, Lars Naver, Thomas Abrahamsson, Georg Bach Jensen, Fredrik Ahlsson, Magnus Domellöf, Anders Elfvin, Lars Naver, Thomas Abrahamsson

Abstract

Introduction: The mortality rate of extremely low gestational age (ELGA) (born <gestational week 28+0) infants remains high, and severe infections and necrotising enterocolitis (NEC) are common causes of death. Preterm infants receiving human milk have lower incidence of sepsis and NEC than those fed a bovine milk-based preterm formula. Despite this, fully human milk fed ELGA infants most often have a significant intake of cow's milk protein from bovine-based protein fortifier. The aim of this study is to evaluate whether the supplementation of human milk-based, as compared with bovine-based, nutrient fortifier reduces the prevalence of NEC, sepsis and mortality in ELGA infants exclusively fed with human milk.

Methods and analysis: A randomised-controlled multicentre trial comparing the effect of a human breast milk-based fortifier with a standard bovine protein-based fortifier in 222-322 ELGA infants fed human breast milk (mother's own milk and/or donor milk). The infants will be randomised to either fortifier before reaching 100 mL/kg/day in oral feeds. The intervention, stratified by centre, will continue until the target postmenstrual week 34+0. The primary outcome is a composite of NEC, sepsis or death. Infants are characterised with comprehensive clinical and nutritional data collected prospectively from birth until hospital discharge. Stool, urine, blood and breast milk samples are collected for analyses in order to study underlying mechanisms. A follow-up focusing on neurological development and growth will be performed at 2 and 5.5 years of age. Health economic analyses will be made.

Ethics and dissemination: The study is conducted according to ICH/GCP guidelines and is approved by the regional ethical review board in Linköping Sweden (Dnr 2018/193-31, Dnr 2018/384-32). Results will be presented at scientific meetings and published in peer-reviewed publications.

Trial registration number: The study was registered with ClinicalTrials.gov NCT03797157, 9 January 2019.

Keywords: developmental neurology & neurodisability; neonatal intensive & critical care; neonatology; nutrition & dietetics.

Conflict of interest statement

Competing interests: TA has got a grant for the present study by Prolacta Bioscience, CA, USA, but none of the investigators have any financial interest in Prolacta Bioscience.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Figures

Figure 1
Figure 1
Summary of the N-Forte study actions. CRF, case report form; NEC, necrotising enterocolitis.

References

    1. Norman M, Hallberg B, Abrahamsson T, et al. . Association between year of birth and 1-year survival among extremely preterm infants in Sweden during 2004-2007 and 2014-2016. JAMA 2019;321:1188–99. 10.1001/jama.2019.2021
    1. Section on Breastfeeding . Breastfeeding and the use of human milk. Pediatrics 2012;129:e827–41. 10.1542/peds.2011-3552
    1. Underwood MA. Human milk for the premature infant. Pediatr Clin North Am 2013;60:189–207. 10.1016/j.pcl.2012.09.008
    1. Arslanoglu S, Corpeleijn W, et al. , ESPGHAN Committee on Nutrition . Donor human milk for preterm infants: current evidence and research directions. J Pediatr Gastroenterol Nutr 2013;57:535–42. 10.1097/MPG.0b013e3182a3af0a
    1. EXPRESS Group . Incidence of and risk factors for neonatal morbidity after active perinatal care: extremely preterm infants study in Sweden (express). Acta Paediatr 2010;99:978–92. 10.1111/j.1651-2227.2010.01846.x
    1. Lin PW, Stoll BJ. Necrotising enterocolitis. The Lancet 2006;368:1271–83. 10.1016/S0140-6736(06)69525-1
    1. Niño DF, Sodhi CP, Hackam DJ. Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol Hepatol 2016;13:590–600. 10.1038/nrgastro.2016.119
    1. Eaton S, Rees CM, Hall NJ. Current research on the epidemiology, pathogenesis, and management of necrotizing enterocolitis. Neonatology 2017;111:423–30. 10.1159/000458462
    1. Roze E, Ta BDP, van der Ree MH, et al. . Functional impairments at school age of children with necrotizing enterocolitis or spontaneous intestinal perforation. Pediatr Res 2011;70:619–25. 10.1203/PDR.0b013e31823279b1
    1. Humberg A, Spiegler J, Fortmann MI, et al. . Surgical necrotizing enterocolitis but not spontaneous intestinal perforation is associated with adverse neurological outcome at school age. Sci Rep 2020;10:2373. 10.1038/s41598-020-58761-6
    1. Ganapathy V, Hay JW, Kim JH. Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants. Breastfeed Med 2012;7:29–37. 10.1089/bfm.2011.0002
    1. Ganapathy V, Hay JW, Kim JH, et al. . Long term healthcare costs of infants who survived neonatal necrotizing enterocolitis: a retrospective longitudinal study among infants enrolled in Texas Medicaid. BMC Pediatr 2013;13:127. 10.1186/1471-2431-13-127
    1. Quigley M, Embleton ND, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2019;7:CD002971. 10.1002/14651858.CD002971.pub5
    1. Narayanan I, Prakash K, Bala S, et al. . Partial supplementation with expressed breast-milk for prevention of infection in low-birth-weight infants. Lancet 1980;2:561–3. 10.1016/S0140-6736(80)91994-7
    1. Narayanan I, Prakash K, Gujral VV. The value of human milk in the prevention of infection in the high-risk low-birth-weight infant. J Pediatr 1981;99:496–8. 10.1016/S0022-3476(81)80360-5
    1. Narayanan I, Prakash K, Murthy NS, et al. . Randomised controlled trial of effect of raw and holder pasteurised human milk and of formula supplements on incidence of neonatal infection. Lancet 1984;2:1111–3. 10.1016/S0140-6736(84)91554-X
    1. Corpeleijn WE, Kouwenhoven SMP, Paap MC, et al. . Intake of own mother's milk during the first days of life is associated with decreased morbidity and mortality in very low birth weight infants during the first 60 days of life. Neonatology 2012;102:276–81. 10.1159/000341335
    1. Horta BL, Loret de Mola C, Victora CG. Breastfeeding and intelligence: a systematic review and meta-analysis. Acta Paediatr 2015;104:14–19. 10.1111/apa.13139
    1. Horta BL, Loret de Mola C, Victora CG. Long-Term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr 2015;104:30–7. 10.1111/apa.13133
    1. Singhal A, Cole TJ, Fewtrell M, et al. . Breastmilk feeding and lipoprotein profile in adolescents born preterm: follow-up of a prospective randomised study. Lancet 2004;363:1571–8. 10.1016/S0140-6736(04)16198-9
    1. Singhal A, Cole TJ, Lucas A. Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials. Lancet 2001;357:413–9. 10.1016/S0140-6736(00)04004-6
    1. Singhal A, Fewtrell M, Cole TJ, et al. . Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet 2003;361:1089–97. 10.1016/S0140-6736(03)12895-4
    1. Fewtrell MS, Williams JE, Singhal A, et al. . Early diet and peak bone mass: 20 year follow-up of a randomized trial of early diet in infants born preterm. Bone 2009;45:142–9. 10.1016/j.bone.2009.03.657
    1. Lucas A, Morley R, Cole TJ, et al. . Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992;339:261–4. 10.1016/0140-6736(92)91329-7
    1. Anderson JW, Johnstone BM, Remley DT. Breast-Feeding and cognitive development: a meta-analysis. Am J Clin Nutr 1999;70:525–35. 10.1093/ajcn/70.4.525
    1. Isaacs EB, Fischl BR, Quinn BT, et al. . Impact of breast milk on intelligence quotient, brain size, and white matter development. Pediatr Res 2010;67:357–62. 10.1203/PDR.0b013e3181d026da
    1. Ehrenkranz RA, Dusick AM, Vohr BR, et al. . Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 2006;117:1253–61. 10.1542/peds.2005-1368
    1. Lucas A, Boscardin J, Abrams SA. Preterm infants fed cow's milk-derived Fortifier had adverse outcomes despite a base diet of only mother's own milk. Breastfeed Med 2020;15:297–303. 10.1089/bfm.2019.0133
    1. Sullivan S, Schanler RJ, Kim JH, et al. . An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010;156:562–7. 10.1016/j.jpeds.2009.10.040
    1. Cristofalo EA, Schanler RJ, Blanco CL, et al. . Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr 2013;163:1592–5. 10.1016/j.jpeds.2013.07.011
    1. O'Connor DL, Kiss A, Tomlinson C, et al. . Nutrient enrichment of human milk with human and bovine milk-based fortifiers for infants born weighing <1250 g: a randomized clinical trial. Am J Clin Nutr 2018;108:108–16. 10.1093/ajcn/nqy067
    1. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103–15. 10.2307/2529712
    1. Bell MJ, Ternberg JL, Feigin RD, et al. . Neonatal necrotizing enterocolitis. therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1–7. 10.1097/00000658-197801000-00001
    1. Gastmeier P, Geffers C, Schwab F, et al. . Development of a surveillance system for nosocomial infections: the component for neonatal intensive care units in Germany. J Hosp Infect 2004;57:126–31. 10.1016/j.jhin.2003.12.038
    1. Hair AB, Peluso AM, Hawthorne KM, et al. . Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk-based diet. Breastfeed Med 2016;11:70–4. 10.1089/bfm.2015.0134
    1. Gould AL. Interim analyses for monitoring clinical trials that do not materially affect the type I error rate. Stat Med 1992;11:55–66. 10.1002/sim.4780110107
    1. Pantiadosi S. Clinical trials: a methodological perspective. 2nd ed. New Jersey: John Wiley & sons, 2005: 384–6.
    1. Haybittle JL. Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol 1971;44:793–7. 10.1259/0007-1285-44-526-793
    1. Rochow N, Fusch G, Zapanta B, et al. . Target fortification of breast milk: how often should milk analysis be done? Nutrients 2015;7:2297–310. 10.3390/nu7042297
    1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723–9. 10.1164/ajrccm.163.7.2011060
    1. International Committee for the Classification of Retinopathy of Prematurity . The International classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;123:991–9. 10.1001/archopht.123.7.991
    1. Papile LA, Burstein J, Burstein R, et al. . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 GM. J Pediatr 1978;92:529–34. 10.1016/S0022-3476(78)80282-0
    1. de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 1992;49:1–6. 10.1016/S0166-4328(05)80189-5
    1. Bayley N. Bayley scales of infant and toddler development. 3rd edn. San Antonio, TX: Harcourt Assessment Inc, 2006.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera